{"id":3056,"date":"2019-01-30T00:00:00","date_gmt":"2019-01-30T00:00:00","guid":{"rendered":"https:\/\/www.registrotumoriveneto.it\/2019\/01\/30\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\/"},"modified":"2019-01-30T00:00:00","modified_gmt":"2019-01-30T00:00:00","slug":"interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2","status":"publish","type":"post","link":"https:\/\/www.registrotumoriveneto.it\/en\/english\/publications\/meetings\/oral-presentations\/2019-oral-presentations\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\/","title":{"rendered":"Interobserver consistency on the histological assessment of spasmolytic polypeptide-expressing metaplasia"},"content":{"rendered":"<p><em>Sacchi D, Guzzardo V, Guzzinati S, Pizzi M, Fassan M, Cesaro S,\u00a0Pennelli G, Maddalo G, Albertoni L, Zanco F, Farinati F, Rugge M<\/em><\/p>\n<p><em>8th Triennial Congress of Pathological Anatomy Siapec-iap 2019<\/em><\/p>\n<p><em>Turin, 16-18 October\u00a0 2019<\/em><\/p>\n<p><!--more--><\/p>\n<p>\u00a0<\/p>\n<p><strong>Abstract<\/strong><\/p>\n<p>Introduction<\/p>\n<p>\u00a0Autoimmune gastritis (AiG), an organ-specific disease restricted to oxyntic mucosa, is mediated by a complex interaction between autoantibodies (against parietal cell proton pump and\/or intrinsic factor), and sensitized T-cells. The long-standing, non-self-limiting inflammation results into progressive destruction of the oxyntic glands, which are replaced by atrophic, non-metaplastic and metaplastic, mucosa (i.e. intestinal metaplasia [IM] and spasmolytic polypeptide-expressing metaplasia [SPEM]). Assessing histologically oxyntic atrophy (an essential step in gastritis staging) involves the distinction between the different atrophic phenotypes, which includes non-metaplastic (disappearance of glandular units replaced by a fibrotic lamina propria), and metaplastic (IM and\/or SPEM) atrophy. SPEM is defined as antral-like (pseudo-pyloric metaplasia in hematoxylin-eosin [H&amp;E]) mucosa, expressing immunohistochemical (IHC) markers natively associated to antral glands (trefoil factor 2 [TFF2]). Aims of this study were: i) to test the inter-observer consistency in the assessment of atrophy (i.e. non-metaplastic atrophy, IM and SPEM) in routine H&amp;E histology; ii) to verify if\/how TFF2-IHC modifies the histological assessment of SPEM, as obtained by H&amp;E; iii) to explore if the SPEM-score, as obtained by applying TFF2-IHC, may result in any modification of the gastritis OLGA-stage as assessed by H&amp;E.<\/p>\n<p>Materials and methods<\/p>\n<p>The study considered a series of 434 biopsy sets obtained from histologically-proved, serologically-confirmed AiG. Inclusion criteria were as follows: i) availability of a standard set of gastric biopsy samples (i.e. Sydney System compliant sets); ii) availability of immunohistochemical profiling, including TFF2 (Proteintech Group, Inc. IL, USA, 1:1500 dilutions; rabbit IgG). The study involved two pathologists working at the same Department (one GI expert [MR] and one in training [SAD]), where they shared the same diagnostic criteria and daily practice. To test the interobserver consistency (IOC) in the H&amp;E assessment of the mucosa atrophy spectrum (non-metaplastic atrophy, IM atrophy, SPEM), 78\/434 randomly selected biopsy sets (H&amp;E stain) were considered by pathologists, who independently reported the atrophy scores. For each of the considered variables, the obtained score values were tested by k statistics.<br \/>All the original 434 histological sets (H&amp;E and TFF2-IHC) were re-considered (SAD), by histologically scoring the whole spectrum of atrophy subtypes (OLGA staging tutorial1). In the biopsy samples obtained from the oxyntic mucosa, SPEM-atrophy was assessed by both H&amp;E and TFF2-IHC; the consistency between the 2 score-values (H&amp;E versus TFF2-IHC) was tested by k statistics.<br \/>Finally, to test if TFF2-IHC SPEM-scores could result in modifying: i) the \u201cglobal\u201d oxyntic score value, ii) and\/or the conclusive OLGA-staging, this study compared the allocation of cases by stage when TFF2-IHC was applied additionally. The strength of association between OLGA stage and the pathological was obtained by applying Student\u2019s t-test and the Wilcoxon non-parametric test for matched pairs, as appropriate. The statistical analysis was performed using the STATA 8.0 software (Stata Corporation, College Station, TX, USA).<\/p>\n<p>Results<\/p>\n<p>Among the 78\/434 biopsy sets reviewed by two pathologists, the IOC was tested by means of k statistics. IOC was ranked as \u2018good\u2019 in corpus IM (no change=84,6%; k coefficient = 0,7656), as well as, in antral IM (no change=93,6%; k coefficient= 0,620), and as \u2018excellent\u2019 in SPEM (no change=88,5%; k coefficient=0,8295). The IOC was ranked as \u2018weak\u2019 in non-metaplastic atrophy (no change=28,2%; higher score=71,8%; k coefficient=0,0314; the discrepancy range: 5% to 15%). \u2018Excellent\u2019 inter-observer consistency was documented in the assessment in the score of both \u201cglobal\u201d oxyntic (no change =100%; k coefficient =1), and \u201cglobal\u201d antral atrophy score (no changes=98,7%; k coefficient =0,926) and, ultimately, in OLGA stage assessment (no change=98,7%; k coefficient = 0,9536). When all the 434 cases were considered, no differences emerged by comparing the SPEM-atrophy scores as obtained from H&amp;E versus TFF2-IHC assessments, (\u2018excellent\u2019 k statistics; no change=85,7%; higher score at TFF2-IHC=7,4%, and lower score at TFF2-IHC=6,9%; k coefficient= 0,8365). Furthermore, no differences emerged in corpus atrophy scores (no change=94,0%; higher score at TFF2-IHC=3,9%, and lower score at TFF2-IHC=2,1%; k coefficient= 0,8997). Finally, \u201cexcellent\u201d consistency emerged in the allocation of cases by OLGA-stage: no change in 95,2%; higher stage at TFF2-IHC in 2,9%, and lower stage at TFF2-IHC in1,8%; k coefficient= 0,889.<\/p>\n<p>Conclusions<\/p>\n<p>In AiG, the present results demonstrate that the TFF2 stain does not significantly improve the histological assessment of SPEM. TFF2-IHC, however, may help pathologists who are not familiar with gastritis atrophy-assessment. In such a diagnostic setting, OLGA-staging of AiG is not significantly modified by the additional information achievable by including TFF2-IHC to the routine histological stain.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sacchi D, Guzzardo V, Guzzinati S, Pizzi M, Fassan M, Cesaro S,\u00a0Pennelli G, Maddalo G, Albertoni L, Zanco F, Farinati F, Rugge M 8th Triennial Congress of Pathological Anatomy Siapec-iap 2019 Turin, 16-18 October\u00a0 2019<\/p>\n","protected":false},"author":18,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_helpful_status":1,"footnotes":""},"categories":[414,694,817],"tags":[],"class_list":["post-3056","post","type-post","status-publish","format-standard","hentry","category-2019-oral-presentations","category-autoimmune-gastritis","category-pathology-records"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Registro Tumori Veneto &#8212; Interobserver consistency on the histological assessment of spasmolytic polypeptide-expressing metaplasia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.registrotumoriveneto.it\/en\/english\/publications\/meetings\/oral-presentations\/2019-oral-presentations\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Registro Tumori Veneto &#8212; Interobserver consistency on the histological assessment of spasmolytic polypeptide-expressing metaplasia\" \/>\n<meta property=\"og:description\" content=\"Sacchi D, Guzzardo V, Guzzinati S, Pizzi M, Fassan M, Cesaro S,\u00a0Pennelli G, Maddalo G, Albertoni L, Zanco F, Farinati F, Rugge M 8th Triennial Congress of Pathological Anatomy Siapec-iap 2019 Turin, 16-18 October\u00a0 2019\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.registrotumoriveneto.it\/en\/english\/publications\/meetings\/oral-presentations\/2019-oral-presentations\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Registro Tumori Veneto\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-30T00:00:00+00:00\" \/>\n<meta name=\"author\" content=\"Emanuela Bovo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emanuela Bovo\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.registrotumoriveneto.it\\\/en\\\/english\\\/publications\\\/meetings\\\/oral-presentations\\\/2019-oral-presentations\\\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.registrotumoriveneto.it\\\/en\\\/english\\\/publications\\\/meetings\\\/oral-presentations\\\/2019-oral-presentations\\\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\\\/\"},\"author\":{\"name\":\"Emanuela Bovo\",\"@id\":\"https:\\\/\\\/www.registrotumoriveneto.it\\\/en\\\/#\\\/schema\\\/person\\\/8d67cfda995ba2b7b0e160ec63503607\"},\"headline\":\"Interobserver consistency on the histological assessment of spasmolytic polypeptide-expressing metaplasia\",\"datePublished\":\"2019-01-30T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.registrotumoriveneto.it\\\/en\\\/english\\\/publications\\\/meetings\\\/oral-presentations\\\/2019-oral-presentations\\\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\\\/\"},\"wordCount\":782,\"commentCount\":0,\"articleSection\":[\"2019\",\"Autoimmune gastritis\",\"Pathology records\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.registrotumoriveneto.it\\\/en\\\/english\\\/publications\\\/meetings\\\/oral-presentations\\\/2019-oral-presentations\\\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.registrotumoriveneto.it\\\/en\\\/english\\\/publications\\\/meetings\\\/oral-presentations\\\/2019-oral-presentations\\\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\\\/\",\"url\":\"https:\\\/\\\/www.registrotumoriveneto.it\\\/en\\\/english\\\/publications\\\/meetings\\\/oral-presentations\\\/2019-oral-presentations\\\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\\\/\",\"name\":\"Registro Tumori Veneto &#8212; Interobserver consistency on the histological assessment of spasmolytic polypeptide-expressing metaplasia\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.registrotumoriveneto.it\\\/en\\\/#website\"},\"datePublished\":\"2019-01-30T00:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.registrotumoriveneto.it\\\/en\\\/#\\\/schema\\\/person\\\/8d67cfda995ba2b7b0e160ec63503607\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.registrotumoriveneto.it\\\/en\\\/english\\\/publications\\\/meetings\\\/oral-presentations\\\/2019-oral-presentations\\\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.registrotumoriveneto.it\\\/en\\\/english\\\/publications\\\/meetings\\\/oral-presentations\\\/2019-oral-presentations\\\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.registrotumoriveneto.it\\\/en\\\/english\\\/publications\\\/meetings\\\/oral-presentations\\\/2019-oral-presentations\\\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.registrotumoriveneto.it\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Interobserver consistency on the histological assessment of spasmolytic polypeptide-expressing metaplasia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.registrotumoriveneto.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.registrotumoriveneto.it\\\/en\\\/\",\"name\":\"Registro Tumori Veneto\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.registrotumoriveneto.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.registrotumoriveneto.it\\\/en\\\/#\\\/schema\\\/person\\\/8d67cfda995ba2b7b0e160ec63503607\",\"name\":\"Emanuela Bovo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/42f9b652e537b087eb6174c62e2271e9b2e7d4c9306299bae89fd42cd78471f3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/42f9b652e537b087eb6174c62e2271e9b2e7d4c9306299bae89fd42cd78471f3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/42f9b652e537b087eb6174c62e2271e9b2e7d4c9306299bae89fd42cd78471f3?s=96&d=mm&r=g\",\"caption\":\"Emanuela Bovo\"},\"url\":\"https:\\\/\\\/www.registrotumoriveneto.it\\\/en\\\/author\\\/emanuela-bovo\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Registro Tumori Veneto &#8212; Interobserver consistency on the histological assessment of spasmolytic polypeptide-expressing metaplasia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.registrotumoriveneto.it\/en\/english\/publications\/meetings\/oral-presentations\/2019-oral-presentations\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\/","og_locale":"en_US","og_type":"article","og_title":"Registro Tumori Veneto &#8212; Interobserver consistency on the histological assessment of spasmolytic polypeptide-expressing metaplasia","og_description":"Sacchi D, Guzzardo V, Guzzinati S, Pizzi M, Fassan M, Cesaro S,\u00a0Pennelli G, Maddalo G, Albertoni L, Zanco F, Farinati F, Rugge M 8th Triennial Congress of Pathological Anatomy Siapec-iap 2019 Turin, 16-18 October\u00a0 2019","og_url":"https:\/\/www.registrotumoriveneto.it\/en\/english\/publications\/meetings\/oral-presentations\/2019-oral-presentations\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\/","og_site_name":"Registro Tumori Veneto","article_published_time":"2019-01-30T00:00:00+00:00","author":"Emanuela Bovo","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Emanuela Bovo","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.registrotumoriveneto.it\/en\/english\/publications\/meetings\/oral-presentations\/2019-oral-presentations\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\/#article","isPartOf":{"@id":"https:\/\/www.registrotumoriveneto.it\/en\/english\/publications\/meetings\/oral-presentations\/2019-oral-presentations\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\/"},"author":{"name":"Emanuela Bovo","@id":"https:\/\/www.registrotumoriveneto.it\/en\/#\/schema\/person\/8d67cfda995ba2b7b0e160ec63503607"},"headline":"Interobserver consistency on the histological assessment of spasmolytic polypeptide-expressing metaplasia","datePublished":"2019-01-30T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.registrotumoriveneto.it\/en\/english\/publications\/meetings\/oral-presentations\/2019-oral-presentations\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\/"},"wordCount":782,"commentCount":0,"articleSection":["2019","Autoimmune gastritis","Pathology records"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.registrotumoriveneto.it\/en\/english\/publications\/meetings\/oral-presentations\/2019-oral-presentations\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.registrotumoriveneto.it\/en\/english\/publications\/meetings\/oral-presentations\/2019-oral-presentations\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\/","url":"https:\/\/www.registrotumoriveneto.it\/en\/english\/publications\/meetings\/oral-presentations\/2019-oral-presentations\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\/","name":"Registro Tumori Veneto &#8212; Interobserver consistency on the histological assessment of spasmolytic polypeptide-expressing metaplasia","isPartOf":{"@id":"https:\/\/www.registrotumoriveneto.it\/en\/#website"},"datePublished":"2019-01-30T00:00:00+00:00","author":{"@id":"https:\/\/www.registrotumoriveneto.it\/en\/#\/schema\/person\/8d67cfda995ba2b7b0e160ec63503607"},"breadcrumb":{"@id":"https:\/\/www.registrotumoriveneto.it\/en\/english\/publications\/meetings\/oral-presentations\/2019-oral-presentations\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.registrotumoriveneto.it\/en\/english\/publications\/meetings\/oral-presentations\/2019-oral-presentations\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.registrotumoriveneto.it\/en\/english\/publications\/meetings\/oral-presentations\/2019-oral-presentations\/interobserver-consistency-on-the-histological-assessment-of-spasmolytic-polypeptide-expressing-metaplasia-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.registrotumoriveneto.it\/en\/"},{"@type":"ListItem","position":2,"name":"Interobserver consistency on the histological assessment of spasmolytic polypeptide-expressing metaplasia"}]},{"@type":"WebSite","@id":"https:\/\/www.registrotumoriveneto.it\/en\/#website","url":"https:\/\/www.registrotumoriveneto.it\/en\/","name":"Registro Tumori Veneto","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.registrotumoriveneto.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.registrotumoriveneto.it\/en\/#\/schema\/person\/8d67cfda995ba2b7b0e160ec63503607","name":"Emanuela Bovo","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/42f9b652e537b087eb6174c62e2271e9b2e7d4c9306299bae89fd42cd78471f3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/42f9b652e537b087eb6174c62e2271e9b2e7d4c9306299bae89fd42cd78471f3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/42f9b652e537b087eb6174c62e2271e9b2e7d4c9306299bae89fd42cd78471f3?s=96&d=mm&r=g","caption":"Emanuela Bovo"},"url":"https:\/\/www.registrotumoriveneto.it\/en\/author\/emanuela-bovo\/"}]}},"_links":{"self":[{"href":"https:\/\/www.registrotumoriveneto.it\/en\/wp-json\/wp\/v2\/posts\/3056","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.registrotumoriveneto.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.registrotumoriveneto.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.registrotumoriveneto.it\/en\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/www.registrotumoriveneto.it\/en\/wp-json\/wp\/v2\/comments?post=3056"}],"version-history":[{"count":0,"href":"https:\/\/www.registrotumoriveneto.it\/en\/wp-json\/wp\/v2\/posts\/3056\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.registrotumoriveneto.it\/en\/wp-json\/wp\/v2\/media?parent=3056"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.registrotumoriveneto.it\/en\/wp-json\/wp\/v2\/categories?post=3056"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.registrotumoriveneto.it\/en\/wp-json\/wp\/v2\/tags?post=3056"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}